CARMAT
CARMAT is a medtech company, offering biocompatible, auto-regulated total artificial hearts as close as possible to the human heart.
CARMAT has raised €85M across 4 funding rounds from 1 investor, most recently a round in Apr 2022. Based in Vélizy-Villacoublay, France; founded 2008; active in AI and Healthtech. Data as of 28 Oct 2026.
Total raised
€85M
€84,900,000
Funding rounds
4
Investors
1
distinct backers
Active since
2018-12
latest 2022-04
Funding by year
EUR raised per yearCARMAT — funding by year — interactive chart.
Data table
| CARMAT — funding by year | |
|---|---|
| 2018 | €30M |
| 2020 | €13M |
| 2021 | €1.4M |
| 2022 | €41M |
Signals
Medium confidenceRaise-next likelihood7
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 4 rounds raised
- ▼ Old (18y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-12 | Other | €41M | — | View deal → |
| 2021-03-09 | Other | €1.4M | — | View deal → |
| 2020-10-12 | Other | €13M | — | View deal → |
| 2018-12-17 | Other | €30M | European Investment Bank (EIB) | View deal → |
Investors
1Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Helsing€2.9BGermany · AI
- Verkor€2.4BFrance · Energy
- UiPath€1.7BRomania · AI
- ContentSquare€1.3BFrance · Software
Global coverage: FundingData